XML 16 R4.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Revenues $ 2,803 $ 823
Cost of revenues 3,364 1,678
Impairment of production line 269 0
Gross loss 830 855
Operating expenses:    
Research and development 2,154 2,565
Sales and marketing 4,739 1,330
General and administrative 3,378 2,948
Total operating expenses 10,271 6,843
Operating loss 11,101 7,698
Financial expenses (income), net:    
Revaluation of warrants (260) (571)
Other financial expense, net 46 15
Total financial expenses (income), net (214) (556)
Net loss 10,887 7,142
Deemed dividend related to May 2015 exchange agreement 0 154
Deemed dividend related to Series A Preferred Stock exchange agreement 455 0
Deemed dividend related to extension of July 2015 Series A warrants in July 2016 265 0
Net loss attributable to holders of Common Stock $ 11,607 $ 7,296
Net loss per share:    
Basic and diluted loss per share (in dollars per share) $ 2.09 $ 3.84
Weighted average number of Common Stock used in computing basic and diluted net loss per share (in shares) 5,202,974 1,897,755